Takeda Pharmaceutical Co. Ltd.'s Fiscal Year is From April To March - All Figures are in JPY, Trillions.
The item "Free-Cash-Flow-To-Equity" stands at 0.0127 Trillion Japanese Yens for the trailing twelve months (TTM) period ending 09/30/2025, the lowest value since 06/30/2024.'
Regarding the One-Year-Change of the series, the current value constitutes an decrease of -0.5053 Trillion Japanese Yens compared to the value the year prior.
The 1 year change is -0.5053 Trillion Japanese Yens.
The 3 year change is -0.5945 Trillion Japanese Yens.
The 5 year change is -0.3022 Trillion Japanese Yens.
The 10 year change is 0.1916 Trillion Japanese Yens.
| Logo | Name | Market Cap (USD) |
|---|---|---|
![]() | Eli Lilly and Company - Free Cash Flow To Equity | 905,699,262,464.00 |
![]() | Johnson & Johnson - Free Cash Flow To Equity | 486,508,953,600.00 |
![]() | AbbVie Inc - Free Cash Flow To Equity | 399,570,305,024.00 |
![]() | Roche Holding AG - Free Cash Flow To Equity | 317,433,206,677.55 |
![]() | AstraZeneca PLC - Free Cash Flow To Equity | 280,205,508,085.11 |